Title:
DRUG ELUTING COATINGS FOR MEDICAL IMPLANTS
Document Type and Number:
WIPO Patent Application WO2004017892
Kind Code:
A3
Abstract:
Drug eluting coating compositions are composed of at least one therapeutic agent dispersed in modified, biologically active binders. The therapeutic agents included in the coating composition are paclitaxel, sirolimus, tacrolimus, everolimus, actinomycin-D, dexamethasone, mycophenolic acid, cyclosporins, estradiol, and derivatives and analogs thereof. These therapeutic agents are applied to the surface of the medical device by a modified, biologically active binders. By using these biologically active binders, the therapeutic agents can be applied to at least one surface of a medical implant without using inert polymer carriers.
Inventors:
HSU LI-CHIEN (US)
Application Number:
PCT/US2003/026364
Publication Date:
July 01, 2004
Filing Date:
August 22, 2003
Export Citation:
Assignee:
HSU LI-CHIEN (US)
International Classes:
A61F2/07; A61L17/00; A61F2/82; A61K31/4745; A61K31/56; A61K31/727; A61L27/00; A61L31/00; A61L31/16; A61L33/10; (IPC1-7): A61J3/00
Foreign References:
| US6179817B1 | 2001-01-30 | |||
| US5837313A | 1998-11-17 | |||
| US5980972A | 1999-11-09 |
Other References:
See also references of EP 1549276A4
Download PDF:
Previous Patent: THERMAL ROLLING DEVICE FOR THERMOTHERAPY SYSTEMS
Next Patent: NUTRITIONAL SUPPLEMENT FOR CHILDREN
Next Patent: NUTRITIONAL SUPPLEMENT FOR CHILDREN